NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2010 to Q3 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 26.8M shares, a 47.7% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 26.8M shares, a 47.7% increase from 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 18.1M shares, a 13.3% increase from 2022.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 16M shares, a 49.6% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 26.8M +8.64M +47.7% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-17
Q2 2024 27.4M +9.77M +55.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 25.9M +9.5M +57.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 24M +7.76M +47.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 18.1M +2.12M +13.3% Jul 1, 2023 Sep 30, 2023 10-K 2024-12-17
Q2 2023 17.6M +1.39M +8.56% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 16.4M +225K +1.39% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 16.2M +823K +5.34% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 16M Jul 1, 2022 Sep 30, 2022 10-K 2023-12-15
Q2 2022 16.2M +4.23M +35.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 16.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 15.4M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q2 2021 12M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q3 2013 4.5M 0 0% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-15
Q2 2013 4.5M 0 0% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-15
Q1 2013 5.07M 0 0% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q4 2012 5.07M +430K +9.26% Oct 1, 2012 Dec 31, 2012 10-K 2013-04-11
Q3 2012 4.5M -55.3K -1.22% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-15
Q2 2012 4.5M 0 0% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-15
Q1 2012 5.07M +573K +12.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 4.64M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-11
Q3 2011 4.56M +55.3K +1.23% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 4.5M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-15
Q1 2011 4.5M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 4.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.